Letter to the Editor
Successful Treatment with Gefitinib in Advanced Non–Small Cell Lung Cancer after Acquired Resistance to Osimertinib

https://doi.org/10.1016/j.jtho.2017.02.014Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Disclosure: The authors declare no conflict of interests.